Drugs Used to Treat Alzheimer's Disease May Reduce MI Risk, Study Finds

According to a Swedish study published recently in the European Heart Journal, use of cholinesterase inhibitors to treat subjects diagnosed with mild to moderate Alzheimer's disease was associated with a reduced risk of myocardial infarction (MI) and death. The observational study, which drew data from a cohort of more than 7,000 patients diagnosed with Alzheimer's dementia or Alzheimer's mixed dementia and enrolled in the Swedish Dementia Registry, was based on the premise that the medications' anti-inflammatory properties and, perhaps, vagotonic side effects, could play a role in reducing the risk of cardiovascular disease, including MI.
Source: AAFP Health of the Public - Category: Primary Care Source Type: news